Divis Laboratories Competitors and Similar CompaniesClear all
Divis Laboratories's competitors and similar companies include Lonza, Teva, Hikma Pharmaceuticals and Sun Pharma.
 Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. |  Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products. |  Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | |||
Founding Date | Founding Date 1990 | Founding Date 1897 | Founding Date 1901 | Founding Date 1978 | Founding Date 1983 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US | Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more | Locations HQ | Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more |
Employees | Employees 7,9267% increase | Employees 19,7712% increase | Employees 29,780 | Employees 9,500 | Employees 43,000 |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹105.6b (FY, 2026) | Revenue (est.) CHF6.5b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $3.3b (FY, 2025) | Revenue (est.) ₹582.2b (FY, 2026) |
Cost of goods | Cost of goods ₹40.9b (FY, 2026) | Cost of goods CHF2.1b (FY, 2025) | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods ₹115.4b (FY, 2026) |
Gross profit | Gross profit ₹69.7b (FY, 2026) | Gross profit CHF4.5b (FY, 2025) | Gross profit N/A | Gross profit $1.7b (FY, 2025) | Gross profit ₹488.9b (FY, 2026) |
Net income | Net income ₹25.7b (FY, 2026) | Net income CHF909m (FY, 2025) | Net income N/A | Net income $407m (FY, 2025) | Net income ₹115.6b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Lonza
HQ
Basel, CH
Employees
19,771↑ 2% increase
Lonza Group is a company specializing in life sciences and biotechnology solutions
View companyHikma Pharmaceuticals
HQ
London, GB
Employees
9,500
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
View companySun Pharma
HQ
Mumbai, IN
Employees
43,000
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company